Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;144(1):109-110.
doi: 10.1111/ane.13451. Epub 2021 May 17.

SARS-CoV-2 vaccines are not free of neurological side effects

Josef Finsterer  1 , Fulvio A Scorza  2
Affiliations
Comment

SARS-CoV-2 vaccines are not free of neurological side effects

Josef Finsterer et al. Acta Neurol Scand. 2021 Jul.
No abstract available

Keywords: COVID-19; SARS-CoV-2; nerves; neurological; neuropathy.

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

References

    1. Lu L, Xiong W, Mu J, et al. The potential neurological effect of the COVID‐19 vaccines: a review. Acta Neurol Scand. 2021. 10.1111/ane.13417 - DOI - PMC - PubMed
    1. Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID‐19 vaccines. Ann Neurol. 2021. 10.1002/ana.26065 - DOI - PMC - PubMed
    1. Bhopal SS, Olabi B, Bhopal R. Vaccines for COVID‐19: learning from ten phase II trials to inform clinical and public health vaccination programmes. Public Health. 2021;29(193):57‐60. 10.1016/j.puhe.2021.01.011 - DOI - PMC - PubMed
    1. Allen A, Szabo L, Kaiser Health News . NIH “Very Concerned” about Serious Side Effect in Coronavirus Vaccine Trial [Internet]. Scientific American; 2020. Available at: https://www.scienticamerican.com/article/nih‐very‐concerned‐about‐seriou.... Accessed March 27, 2021
    1. Repajic M, Lai XL, Xu P, Liu A. Bell's Palsy after second dose of Pfizer COVID‐19 vaccination in a patient with history of recurrent Bell's palsy. Brain Behav Immun Health. 2021;13:100217. 10.1016/j.bbih.2021.100217 - DOI - PMC - PubMed

Substances